open access

Vol 6, No 6 (2005): Practical Diabetology
Research paper
Submitted: 2012-01-02
Published online: 2005-11-03
Get Citation

Hypoglycaemic episodes in patients with diabetes in course of liver cirrhosis

Leszek Markuszewski, Michał Możdżan, Michał Barański, Jan Ruxer
DOI: 10.5603/cd.8589
·
Diabetologia Praktyczna 2005;6(6):307-311.

open access

Vol 6, No 6 (2005): Practical Diabetology
Original articles
Submitted: 2012-01-02
Published online: 2005-11-03

Abstract

INTRODUCTION. The aim of the study was to evaluate hypoglycaemic episodes, including symptomfree events detected with continuous glucose monitoring system (CGMS) in patients with diabetes mellitus in course of liver cirrhosis.
MATERIAL AND METHODS. 18 patients with diabetes in course of liver cirrhosis and 18 type 2 diabetic patients (control group) were enrolled into the study. All patients were treated with insulin. During 72 hours glucose values with CGMS was measured, insulin treatment was not modified. The state of hypoglycemia assumed as glucose value < 60 mg/dl. Duration and number of hypoglycaemic events, including symptom-free hypoglycaemic episodes were analyzed in both groups.
RESULTS. Mean number of hypoglycaemic events detected with CGMS for three days was higher for patients with hepatogenous diabetes than for type 2 patients (p = 0.02). Mean number of symptom-free hypoglycaemic events detected with CGMS was statistically similar in both groups (NS). Mean duration of hypoglycaemic episodes, including symptom-free hypoglycaemic episodes was similar in both groups (NS).
CONCLUSIONS. It was concluded, that hepatogenic diabetes is associated with essentially higher number of hypoglycaemic events than type 2 diabetes. CGMS is useful in diabetic patients with liver cirrhosis for hypoglycaemic episodes detection.

Abstract

INTRODUCTION. The aim of the study was to evaluate hypoglycaemic episodes, including symptomfree events detected with continuous glucose monitoring system (CGMS) in patients with diabetes mellitus in course of liver cirrhosis.
MATERIAL AND METHODS. 18 patients with diabetes in course of liver cirrhosis and 18 type 2 diabetic patients (control group) were enrolled into the study. All patients were treated with insulin. During 72 hours glucose values with CGMS was measured, insulin treatment was not modified. The state of hypoglycemia assumed as glucose value < 60 mg/dl. Duration and number of hypoglycaemic events, including symptom-free hypoglycaemic episodes were analyzed in both groups.
RESULTS. Mean number of hypoglycaemic events detected with CGMS for three days was higher for patients with hepatogenous diabetes than for type 2 patients (p = 0.02). Mean number of symptom-free hypoglycaemic events detected with CGMS was statistically similar in both groups (NS). Mean duration of hypoglycaemic episodes, including symptom-free hypoglycaemic episodes was similar in both groups (NS).
CONCLUSIONS. It was concluded, that hepatogenic diabetes is associated with essentially higher number of hypoglycaemic events than type 2 diabetes. CGMS is useful in diabetic patients with liver cirrhosis for hypoglycaemic episodes detection.
Get Citation

Keywords

diabetes mellitus; cirrhosis hepatis; hypoglycaemia; continuous glucose monitoring system

About this article
Title

Hypoglycaemic episodes in patients with diabetes in course of liver cirrhosis

Journal

Clinical Diabetology

Issue

Vol 6, No 6 (2005): Practical Diabetology

Article type

Research paper

Pages

307-311

Published online

2005-11-03

Page views

500

Article views/downloads

2159

DOI

10.5603/cd.8589

Bibliographic record

Diabetologia Praktyczna 2005;6(6):307-311.

Keywords

diabetes mellitus
cirrhosis hepatis
hypoglycaemia
continuous glucose monitoring system

Authors

Leszek Markuszewski
Michał Możdżan
Michał Barański
Jan Ruxer

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl